FTC's Drop Of Illumina-Grail Federal Court Case Raises Uncertainty

Law360 (June 9, 2021, 5:05 PM EDT) -- A federal judge recently dismissed the Federal Trade Commission's challenge of Illumina Inc.'s acquisition of Grail Inc., a cancer-screening firm started and spun off years earlier by Illumina itself.

 

A victory for the defendants? Not so much.

After many months of trying to convince the FTC their merger will speed up approval for Grail's potentially life-saving technology, the move by the U.S. District Court for the Southern District of California under Judge Cathy Ann Bencivengo has left the defendants with even more uncertainty about the future of their deal.

By way of background, Illumina founded Grail in 2016 and subsequently...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!